September 2026 — Amiens, France
At Glyx Therapeutics, our molecule, an anionic lipidic oligosaccharide, targets Alzheimer’s disease and tauopathies. Our innovation does not stop there: we are developing the production of this molecule at pharmaceutical (GMP) grade, entirely following green chemistry principles, with electrosynthesis and mechanosynthesis.
Sustainable Day, Amiens, November 5, 2026
Glyx Therapeutics will take part in the Sustainable Day, a scientific day organized jointly by the e-sense and Chimie Verte Academy programmes (France 2030). It will bring together 100 to 150 students, doctoral and post-doctoral researchers, teachers and researchers around three themes:
- Electrical energy storage
- Green chemistry
- Emerging techniques and technologies for the challenges of the 21st century
The programme includes 6 plenary lectures, short oral communications and a poster session, at the Université de Picardie Jules Verne (energy HUB). Entry is free, with mandatory registration.
Learn more about our pipeline, our research on tauopathies and Alzheimer’s disease, or about Glyx Therapeutics.
